サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1500392

次世代IVD市場：製品、用途、エンドユーザー別-2024-2030年の世界予測

Next-Generation IVD Market by Product (Consumables, Instruments, Software), Application (Autoimmune Diseases, Cardiology, Diabetes), End-user - Global Forecast 2024-2030
出版日: | 発行: 360iResearch | ページ情報: 英文 194 Pages | 納期: 即日から翌営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=155.13円
次世代IVD市場：製品、用途、エンドユーザー別-2024-2030年の世界予測
出版日: 2024年06月05日
発行: 360iResearch
ページ情報: 英文 194 Pages
納期: 即日から翌営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

次世代IVD市場規模は2023年に625億2,000万米ドルと推定され、2024年には656億米ドルに達し、CAGR 5.23%で2030年には893億9,000万米ドルに達すると予測されます。

次世代体外診断薬（IVD）とは、試験管や実験室のような管理された環境で、人体外で実施される高度な診断テストを指します。これらの革新的な診断法は、病気、状態、感染症のより正確、迅速、効率的な検出とモニタリングを提供するために設計された様々な技術、ツール、方法を包含します。次世代」という用語は、分子診断、ポイントオブケア技術、デジタルヘルス技術の進歩を取り入れたこれらの診断法が、従来の方法よりも大幅に強化されていることを強調しています。一方、感染症や慢性疾患の世界の蔓延が次世代体外診断薬の成長を後押ししています。しかし、次世代体外診断用医薬品の規制状況は複雑かつ厳しく、承認に時間がかかることが多いです。さらに、保険償還政策が必ずしも新規の診断技術に有利とは限らず、市場浸透に影響を与えています。さらに、次世代シーケンシング、ポリメラーゼ連鎖反応（PCR）、バイオチップなどの技術革新が進み、診断検査の精度、スピード、信頼性が大幅に向上しているため、次世代IVDソリューションの需要が高まっています。

主な市場の統計
基準年[2023］ 625億2,000万米ドル
予測年[2024］ 656億米ドル
予測年 [2030] 893億9,000万米ドル
CAGR（%） 5.23%

地域別インサイト

南北アメリカでは、米国とカナダが研究開発の最前線にあり、研究への多額の投資と強力な特許の枠組みがこれに拍車をかけています。疾病の早期発見と個別化治療の利点に対する消費者の高い意識が、この地域の高度な体外診断用医薬品（IVD）ソリューションへの需要を後押ししています。国家保健プログラムに次世代診断法を取り入れることに焦点を当てた最近の政府の取り組みが、次世代体外診断用医薬品の需要をさらに押し上げています。EMEA（欧州・中東・アフリカ）地域は、力強い成長と革新的な技術進歩が特徴です。この市場を牽引しているのは、慢性疾患の増加、診断におけるゲノミクスとプロテオミクスの統合です。EMEA全体の規制環境もまた、患者の安全性を確保しながらイノベーションを促進することを目指して適応しており、市場力学において極めて重要な役割を果たしています。さらに、アジア太平洋地域における次世代体外診断用医薬品へのシフトは、主にヘルスケア分野における迅速、正確、個別化された診断ソリューションに対する需要の高まりによって後押しされています。この地域は人口が多く高齢化が進んでおり、病気の早期発見に対する意識が高まっていることが、市場を前進させる主な要因となっています。さらに、ヘルスケアインフラとアクセシビリティの向上を目指した政府の取り組みと研究開発への投資が、先進的なIVD技術の統合を促進しています。

FPNVポジショニング・マトリックス

FPNVポジショニングマトリックスは、次世代IVD市場におけるベンダーのポジショニングを評価する上で不可欠です。このマトリックスはベンダーの包括的な評価を提供し、ビジネス戦略や製品満足度に関連する重要な指標を検証します。この詳細な評価により、ユーザーは自らの要件に沿った十分な情報に基づいた意思決定を行うことができます。評価に基づき、ベンダーは成功のレベルを表す4つの象限、すなわちForefront（F）、Pathfinder（P）、Niche（N）、Vital（V）に分類されます。

市場シェア分析

市場シェア分析は、次世代IVD市場におけるベンダーの現状について、洞察に満ちた詳細な評価を提供する包括的なツールです。ベンダーの貢献度を綿密に比較・分析することで、各ベンダーの業績や市場シェア争いの際に直面する課題について、より深い理解を得ることができます。これらの貢献には、全体的な収益、顧客ベース、その他の重要な指標が含まれます。さらに、この分析では、調査した基準年の期間に観察された蓄積、断片化の優位性、合併の特徴などの要因を含む、この分野の競合性に関する貴重な考察を提供しています。このような詳細な情報を得ることで、ベンダーは市場競争において優位に立つために、より多くの情報に基づいた意思決定を行い、効果的な戦略を考案することができます。

戦略分析と推奨

戦略分析は、世界マーケットで確固たる足場を築こうとする組織にとって不可欠です。企業は、次世代IVD市場における現在の立ち位置を徹底的に評価することで、長期的な願望に沿った情報に基づいた意思決定を行うことができます。この重要な評価には、組織のリソース、能力、全体的なパフォーマンスを徹底的に分析し、中核となる強みと改善すべき領域を特定することが含まれます。

目次

第1章 序文

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 市場の概要

第5章 市場洞察

  • 市場力学
    • 促進要因
      • 世界中で高齢化が進み、慢性疾患の罹患率も増加している
      • 次世代IVD検査の採用拡大による精密医療の向上
    • 抑制要因
      • 患者ケアの改善には適切なヘルスケア専門家が必要
    • 機会
      • 次世代IVDに使用される技術の進歩
      • IVD業界におけるポイントオブケア（POC）検査の採用増加
    • 課題
      • 次世代IVDに影響を与える厳しい規制
  • 市場セグメンテーション分析
    • 製品：体外診断における消耗品の活用による精度と再現性の確保
    • 用途：幅広い感染症や慢性疾患に対応するための次世代IVD技術の進歩
  • 市場ディスラプション分析
  • ポーターのファイブフォース分析
  • バリューチェーンとクリティカルパス分析
  • 価格分析
  • 技術分析
  • 特許分析
  • 貿易分析
  • 規制枠組みの分析

第6章 次世代IVD市場：製品別

  • 消耗品
  • 機器
  • ソフトウェア

第7章 次世代IVD市場：用途別

  • 自己免疫疾患
  • 心臓病学
  • 糖尿病
  • 感染症
  • 腎臓学
  • 腫瘍学

第8章 次世代IVD市場：エンドユーザー別

  • 学術・調査機関
  • 診断検査室
  • 病院・クリニック

第9章 南北アメリカの次世代IVD市場

  • アルゼンチン
  • ブラジル
  • カナダ
  • メキシコ
  • 米国

第10章 アジア太平洋地域の次世代IVD市場

  • オーストラリア
  • 中国
  • インド
  • インドネシア
  • 日本
  • マレーシア
  • フィリピン
  • シンガポール
  • 韓国
  • 台湾
  • タイ
  • ベトナム

第11章 欧州・中東・アフリカの次世代IVD市場

  • デンマーク
  • エジプト
  • フィンランド
  • フランス
  • ドイツ
  • イスラエル
  • イタリア
  • オランダ
  • ナイジェリア
  • ノルウェー
  • ポーランド
  • カタール
  • ロシア
  • サウジアラビア
  • 南アフリカ
  • スペイン
  • スウェーデン
  • スイス
  • トルコ
  • アラブ首長国連邦
  • 英国

第12章 競合情勢

  • 市場シェア分析2023
  • FPNVポジショニングマトリックス, 2023
  • 競合シナリオ分析
    • 戦略的コラボレーション：イルミナとデバイサー・ダイアグノスティクスがIVDイノベーションの道を切り開く
    • Fapon BiotechはIVDの情勢を前進させ、次世代治療薬の拡大を目指す
    • ウォーターズコーポレーション、革新的なXevo TQ Absolute IVD質量分析計を発表
  • 戦略分析と提言

第13章 競合ポートフォリオ

  • 主要企業プロファイル
  • 主要製品ポートフォリオ
図表

LIST OF FIGURES

  • FIGURE 1. NEXT-GENERATION IVD MARKET RESEARCH PROCESS
  • FIGURE 2. NEXT-GENERATION IVD MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL NEXT-GENERATION IVD MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. NEXT-GENERATION IVD MARKET DYNAMICS
  • FIGURE 7. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 8. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 12. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 14. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 16. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. ASIA-PACIFIC NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. ASIA-PACIFIC NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 21. NEXT-GENERATION IVD MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 22. NEXT-GENERATION IVD MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. NEXT-GENERATION IVD MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL NEXT-GENERATION IVD MARKET SIZE, 2018-2023 (USD MILLION)
  • TABLE 4. GLOBAL NEXT-GENERATION IVD MARKET SIZE, 2024-2030 (USD MILLION)
  • TABLE 5. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 6. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 7. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 8. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 9. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 10. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CONSUMABLES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 11. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 12. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY INSTRUMENTS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 13. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY SOFTWARE, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 14. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY SOFTWARE, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 15. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 16. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 17. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 18. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY AUTOIMMUNE DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 19. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CARDIOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 20. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY CARDIOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 21. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY DIABETES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 22. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY DIABETES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 23. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 24. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY INFECTIOUS DISEASES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 25. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY NEPHROLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 26. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY NEPHROLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 27. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY ONCOLOGY, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 28. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY ONCOLOGY, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 29. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 30. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 31. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 32. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTIONS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 33. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 34. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY DIAGNOSTIC LABORATORIES, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 35. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2023 (USD MILLION)
  • TABLE 36. GLOBAL NEXT-GENERATION IVD MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2024-2030 (USD MILLION)
  • TABLE 37. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 38. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 39. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 40. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 41. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 42. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 43. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 44. AMERICAS NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 45. ARGENTINA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 46. ARGENTINA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 47. ARGENTINA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 48. ARGENTINA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 49. ARGENTINA NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 50. ARGENTINA NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 51. BRAZIL NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 52. BRAZIL NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 53. BRAZIL NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 54. BRAZIL NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 55. BRAZIL NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 56. BRAZIL NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 57. CANADA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 58. CANADA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 59. CANADA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 60. CANADA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 61. CANADA NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 62. CANADA NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 63. MEXICO NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 64. MEXICO NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 65. MEXICO NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 66. MEXICO NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 67. MEXICO NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 68. MEXICO NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 69. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 70. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 71. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 72. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 73. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 74. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 75. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY STATE, 2018-2023 (USD MILLION)
  • TABLE 76. UNITED STATES NEXT-GENERATION IVD MARKET SIZE, BY STATE, 2024-2030 (USD MILLION)
  • TABLE 77. ASIA-PACIFIC NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 78. ASIA-PACIFIC NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 79. ASIA-PACIFIC NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 80. ASIA-PACIFIC NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 81. ASIA-PACIFIC NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 82. ASIA-PACIFIC NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 83. ASIA-PACIFIC NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 84. ASIA-PACIFIC NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 85. AUSTRALIA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 86. AUSTRALIA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 87. AUSTRALIA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 88. AUSTRALIA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 89. AUSTRALIA NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 90. AUSTRALIA NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 91. CHINA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 92. CHINA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 93. CHINA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 94. CHINA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 95. CHINA NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 96. CHINA NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 97. INDIA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 98. INDIA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 99. INDIA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 100. INDIA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 101. INDIA NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 102. INDIA NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 103. INDONESIA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 104. INDONESIA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 105. INDONESIA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 106. INDONESIA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 107. INDONESIA NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 108. INDONESIA NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 109. JAPAN NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 110. JAPAN NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 111. JAPAN NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 112. JAPAN NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 113. JAPAN NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 114. JAPAN NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 115. MALAYSIA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 116. MALAYSIA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 117. MALAYSIA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 118. MALAYSIA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 119. MALAYSIA NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 120. MALAYSIA NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 121. PHILIPPINES NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 122. PHILIPPINES NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 123. PHILIPPINES NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 124. PHILIPPINES NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 125. PHILIPPINES NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 126. PHILIPPINES NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 127. SINGAPORE NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 128. SINGAPORE NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 129. SINGAPORE NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 130. SINGAPORE NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 131. SINGAPORE NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 132. SINGAPORE NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 133. SOUTH KOREA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 134. SOUTH KOREA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 135. SOUTH KOREA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 136. SOUTH KOREA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 137. SOUTH KOREA NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 138. SOUTH KOREA NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 139. TAIWAN NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 140. TAIWAN NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 141. TAIWAN NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 142. TAIWAN NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 143. TAIWAN NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 144. TAIWAN NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 145. THAILAND NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 146. THAILAND NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 147. THAILAND NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 148. THAILAND NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 149. THAILAND NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 150. THAILAND NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 151. VIETNAM NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 152. VIETNAM NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 153. VIETNAM NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 154. VIETNAM NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 155. VIETNAM NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 156. VIETNAM NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 157. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 158. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 159. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 160. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 161. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 162. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 163. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2018-2023 (USD MILLION)
  • TABLE 164. EUROPE, MIDDLE EAST & AFRICA NEXT-GENERATION IVD MARKET SIZE, BY COUNTRY, 2024-2030 (USD MILLION)
  • TABLE 165. DENMARK NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 166. DENMARK NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 167. DENMARK NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 168. DENMARK NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 169. DENMARK NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 170. DENMARK NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 171. EGYPT NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 172. EGYPT NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 173. EGYPT NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 174. EGYPT NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 175. EGYPT NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 176. EGYPT NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 177. FINLAND NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 178. FINLAND NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 179. FINLAND NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 180. FINLAND NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 181. FINLAND NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 182. FINLAND NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 183. FRANCE NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 184. FRANCE NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 185. FRANCE NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 186. FRANCE NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 187. FRANCE NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 188. FRANCE NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 189. GERMANY NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 190. GERMANY NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 191. GERMANY NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 192. GERMANY NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 193. GERMANY NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 194. GERMANY NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 195. ISRAEL NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 196. ISRAEL NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 197. ISRAEL NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 198. ISRAEL NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 199. ISRAEL NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 200. ISRAEL NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 201. ITALY NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 202. ITALY NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 203. ITALY NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 204. ITALY NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 205. ITALY NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 206. ITALY NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 207. NETHERLANDS NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 208. NETHERLANDS NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 209. NETHERLANDS NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 210. NETHERLANDS NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 211. NETHERLANDS NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 212. NETHERLANDS NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 213. NIGERIA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 214. NIGERIA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 215. NIGERIA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 216. NIGERIA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 217. NIGERIA NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 218. NIGERIA NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 219. NORWAY NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 220. NORWAY NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 221. NORWAY NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 222. NORWAY NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 223. NORWAY NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 224. NORWAY NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 225. POLAND NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 226. POLAND NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 227. POLAND NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 228. POLAND NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 229. POLAND NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 230. POLAND NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 231. QATAR NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 232. QATAR NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 233. QATAR NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 234. QATAR NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 235. QATAR NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 236. QATAR NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 237. RUSSIA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 238. RUSSIA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 239. RUSSIA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 240. RUSSIA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 241. RUSSIA NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 242. RUSSIA NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 243. SAUDI ARABIA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 244. SAUDI ARABIA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 245. SAUDI ARABIA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 246. SAUDI ARABIA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 247. SAUDI ARABIA NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 248. SAUDI ARABIA NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 249. SOUTH AFRICA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 250. SOUTH AFRICA NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 251. SOUTH AFRICA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 252. SOUTH AFRICA NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 253. SOUTH AFRICA NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 254. SOUTH AFRICA NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 255. SPAIN NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 256. SPAIN NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 257. SPAIN NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 258. SPAIN NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 259. SPAIN NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 260. SPAIN NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 261. SWEDEN NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 262. SWEDEN NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 263. SWEDEN NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 264. SWEDEN NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 265. SWEDEN NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 266. SWEDEN NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 267. SWITZERLAND NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 268. SWITZERLAND NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 269. SWITZERLAND NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 270. SWITZERLAND NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 271. SWITZERLAND NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 272. SWITZERLAND NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 273. TURKEY NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 274. TURKEY NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 275. TURKEY NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 276. TURKEY NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 277. TURKEY NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 278. TURKEY NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 279. UNITED ARAB EMIRATES NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 280. UNITED ARAB EMIRATES NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 281. UNITED ARAB EMIRATES NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 282. UNITED ARAB EMIRATES NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 283. UNITED ARAB EMIRATES NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 284. UNITED ARAB EMIRATES NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 285. UNITED KINGDOM NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2018-2023 (USD MILLION)
  • TABLE 286. UNITED KINGDOM NEXT-GENERATION IVD MARKET SIZE, BY PRODUCT, 2024-2030 (USD MILLION)
  • TABLE 287. UNITED KINGDOM NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2018-2023 (USD MILLION)
  • TABLE 288. UNITED KINGDOM NEXT-GENERATION IVD MARKET SIZE, BY APPLICATION, 2024-2030 (USD MILLION)
  • TABLE 289. UNITED KINGDOM NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2018-2023 (USD MILLION)
  • TABLE 290. UNITED KINGDOM NEXT-GENERATION IVD MARKET SIZE, BY END-USER, 2024-2030 (USD MILLION)
  • TABLE 291. NEXT-GENERATION IVD MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 292. NEXT-GENERATION IVD MARKET, FPNV POSITIONING MATRIX, 2023
目次
Product Code: MRR-2E76C3E47F6A

[194 Pages Report] The Next-Generation IVD Market size was estimated at USD 62.52 billion in 2023 and expected to reach USD 65.60 billion in 2024, at a CAGR 5.23% to reach USD 89.39 billion by 2030.

Next-Generation In Vitro Diagnostics (IVD) refers to the advanced phase of diagnostics tests conducted outside a human body, in a controlled environment such as a test tube or a laboratory. These innovative diagnostics encompass various technologies, tools, and methods designed to offer more precise, faster, and more efficient detection and monitoring of diseases, conditions, and infections. The term 'Next-Generation' underscores the significant enhancements these diagnostics represent over traditional methods, incorporating advancements in molecular diagnostics, point-of-care techniques, and digital health technologies. Meanwhile, the growing prevalence of infectious and chronic diseases worldwide is propelling the growth of next-generation IVDs. However, the regulatory landscape for next-generation IVDs can be complex and rigorous, often resulting in longer approval times. Additionally, reimbursement policies may not always favor novel diagnostic technologies, impacting their market penetration. Moreover, continuous innovation in technologies such as next-generation sequencing, polymerase chain reaction (PCR), and biochips are significantly enhancing diagnostic tests' accuracy, speed, and reliability, thus driving the demand for next-generation IVD solutions.

KEY MARKET STATISTICS
Base Year [2023] USD 62.52 billion
Estimated Year [2024] USD 65.60 billion
Forecast Year [2030] USD 89.39 billion
CAGR (%) 5.23%

Regional Insights

In the Americas, the United States and Canada are at the forefront of next-generation IVD development, spurred by significant investments in research and a strong patent framework. High consumer awareness about the benefits of early disease detection and personalized treatment plans drives the region's demand for advanced IVD solutions. Recent government initiatives focused on incorporating next-generation diagnostics in national health programs further drive the demand for next-generation IVDs. The EMEA region has been characterized by robust growth and transformative technological advancements. The market is driven by the increasing prevalence of chronic diseases and the integration of genomics and proteomics in diagnostics. Regulatory environments across EMEA have also adapted, aiming to foster innovation while ensuring patient safety, thereby playing a pivotal role in market dynamics. Moreover, the shift towards next-generation IVDs in the Asia-Pacific region is primarily fueled by the increasing demand for fast, accurate, and personalized diagnostic solutions across the healthcare sector. The region's large and aging population and the growing awareness about early disease detection are key factors propelling the market forward. Furthermore, government initiatives aimed at improving healthcare infrastructure and accessibility, coupled with investments in research and development, are facilitating the integration of advanced IVD technologies.

Market Insights

  • Market Dynamics

The market dynamics represent an ever-changing landscape of the Next-Generation IVD Market by providing actionable insights into factors, including supply and demand levels. Accounting for these factors helps design strategies, make investments, and formulate developments to capitalize on future opportunities. In addition, these factors assist in avoiding potential pitfalls related to political, geographical, technical, social, and economic conditions, highlighting consumer behaviors and influencing manufacturing costs and purchasing decisions.

    • Market Drivers
      • Rising aging population across the globe and growing prevalence of chronic diseases
      • Increasing adoption next generation IVD tests to improve precision medicine
    • Market Restraints
      • Need of appropriate healthcare professionals to improve patient care
    • Market Opportunities
      • Advancements in technology used for next generation IVD
      • Rising adoption of Point-of-care (POC) testing in IVD industry
    • Market Challenges
      • Stringent regulations impacting the next generation IVD
  • Market Segmentation Analysis
    • Product: Utilization of consumables in an in-vitro diagnostics to ensure the accuracy and reproducibility
    • Application: Advancement in the next-generation IVD technology to cater wide array of infectious and chronic diseases
  • Market Disruption Analysis
  • Porter's Five Forces Analysis
  • Value Chain & Critical Path Analysis
  • Pricing Analysis
  • Technology Analysis
  • Patent Analysis
  • Trade Analysis
  • Regulatory Framework Analysis

FPNV Positioning Matrix

The FPNV positioning matrix is essential in evaluating the market positioning of the vendors in the Next-Generation IVD Market. This matrix offers a comprehensive assessment of vendors, examining critical metrics related to business strategy and product satisfaction. This in-depth assessment empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success, namely Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The market share analysis is a comprehensive tool that provides an insightful and in-depth assessment of the current state of vendors in the Next-Generation IVD Market. By meticulously comparing and analyzing vendor contributions, companies are offered a greater understanding of their performance and the challenges they face when competing for market share. These contributions include overall revenue, customer base, and other vital metrics. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With these illustrative details, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Recent Developments

Strategic Collaboration: Illumina and Devyser Diagnostics Forge Path in IVD Innovation

Illumina, the pioneer in DNA sequencing and array-based technologies, has entered a strategic agreement with Devyser Diagnostics. By leveraging Illumina's formidable expertise in genomics alongside Devyser Diagnostics' specialized focus on diagnostic testing solutions, this collaboration marks a critical step forward in developing novel IVD offerings. [Published On: 2024-01-08]

Fapon Biotech Advances IVD Landscape and Targets Next-Generation Therapeutics Expansion

Fapon Biotech is strategically expanding its comprehensive solutions, encompassing IVD raw materials and end-use product development services. This initiative is characterized by their significant investments in next-generation therapeutics, specifically in infectious diseases and oncology. [Published On: 2023-09-15]

Waters Corporation Introduces Revolutionary Xevo TQ Absolute IVD Mass Spectrometer

Waters Corporation unveiled the Xevo TQ Absolute IVD Mass Spectrometer, poised to redefine efficiency and sensitivity in clinical diagnostics. This cutting-edge instrument departs from traditional mass spectrometry techniques by offering unparalleled analytical performance and ease of use. The Xevo TQ Absolute IVD stands out for its remarkably compact design, which requires 50% less bench space, alongside an enhanced sensitivity that promises to accelerate lab workflows by doubling the number of tests conducted within the same timeframe. [Published On: 2023-04-04]

Strategy Analysis & Recommendation

The strategic analysis is essential for organizations seeking a solid foothold in the global marketplace. Companies are better positioned to make informed decisions that align with their long-term aspirations by thoroughly evaluating their current standing in the Next-Generation IVD Market. This critical assessment involves a thorough analysis of the organization's resources, capabilities, and overall performance to identify its core strengths and areas for improvement.

Key Company Profiles

The report delves into recent significant developments in the Next-Generation IVD Market, highlighting leading vendors and their innovative profiles. These include ABL SA Group, Agilent Technologies Inc., Archer by Integrated DNA Technologies, Inc., Becton, Dickinson and Company, Biomerieux SA, BioVendor - Laboratorni medicina A.S., Cerba Research NV, Curetis N.V., Danaher Corporation, F. Hoffmann-La Roche Ltd., Fapon Biotech Inc., Fulgent Genetics, Inc., Geneseeq Technology Inc., Genomic Labs Ltd., Illumina, Inc., Invivoscribe, Inc., NGenBio Co., Ltd., Otsuka Pharmaceutical Co., Ltd., Pillar Biosciences Inc., QIAGEN GmbH, Sophia Genetics SA, Sysmex Europe SE, Tempus Labs, Inc., Thermo Fisher Scientific Inc., Trivitron Healthcare, and Vela Diagnostics Holding Pte Ltd..

Market Segmentation & Coverage

This research report categorizes the Next-Generation IVD Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Product
    • Consumables
    • Instruments
    • Software
  • Application
    • Autoimmune Diseases
    • Cardiology
    • Diabetes
    • Infectious Diseases
    • Nephrology
    • Oncology
  • End-user
    • Academic & Research Institutions
    • Diagnostic Laboratories
    • Hospitals & Clinics
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising aging population across the globe and growing prevalence of chronic diseases
      • 5.1.1.2. Increasing adoption next generation IVD tests to improve precision medicine
    • 5.1.2. Restraints
      • 5.1.2.1. Need of appropriate healthcare professionals to improve patient care
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in technology used for next generation IVD
      • 5.1.3.2. Rising adoption of Point-of-care (POC) testing in IVD industry
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulations impacting the next generation IVD
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Utilization of consumables in an in-vitro diagnostics to ensure the accuracy and reproducibility
    • 5.2.2. Application: Advancement in the next-generation IVD technology to cater wide array of infectious and chronic diseases
  • 5.3. Market Disruption Analysis
  • 5.4. Porter's Five Forces Analysis
    • 5.4.1. Threat of New Entrants
    • 5.4.2. Threat of Substitutes
    • 5.4.3. Bargaining Power of Customers
    • 5.4.4. Bargaining Power of Suppliers
    • 5.4.5. Industry Rivalry
  • 5.5. Value Chain & Critical Path Analysis
  • 5.6. Pricing Analysis
  • 5.7. Technology Analysis
  • 5.8. Patent Analysis
  • 5.9. Trade Analysis
  • 5.10. Regulatory Framework Analysis

6. Next-Generation IVD Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
  • 6.3. Instruments
  • 6.4. Software

7. Next-Generation IVD Market, by Application

  • 7.1. Introduction
  • 7.2. Autoimmune Diseases
  • 7.3. Cardiology
  • 7.4. Diabetes
  • 7.5. Infectious Diseases
  • 7.6. Nephrology
  • 7.7. Oncology

8. Next-Generation IVD Market, by End-user

  • 8.1. Introduction
  • 8.2. Academic & Research Institutions
  • 8.3. Diagnostic Laboratories
  • 8.4. Hospitals & Clinics

9. Americas Next-Generation IVD Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Next-Generation IVD Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Next-Generation IVD Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
    • 12.3.1. Strategic Collaboration: Illumina and Devyser Diagnostics Forge Path in IVD Innovation
    • 12.3.2. Fapon Biotech Advances IVD Landscape and Targets Next-Generation Therapeutics Expansion
    • 12.3.3. Waters Corporation Introduces Revolutionary Xevo TQ Absolute IVD Mass Spectrometer
  • 12.4. Strategy Analysis & Recommendation

13. Competitive Portfolio

  • 13.1. Key Company Profiles
  • 13.2. Key Product Portfolio